Ligand Pharmaceuticals LGND
NASDAQ LGND
$302.74 -9.63 (-3.08%)
At close: Oct 1, 2026 · 4:00 PM EDT

Ligand Pharmaceuticals (LGND) Intangibles (2010 - 2026)

Updated

Ligand Pharmaceuticals' Intangibles was $209.24 million in Q2 2026, down 16.3% from $250.13 million a year earlier and down 3.7% from the prior quarter.

Analysis

Ligand Pharmaceuticals (LGND) Intangibles (2010 - 2026) Analysis & Trends

At the end of FY2025, Intangibles at Ligand Pharmaceuticals came in at $225.44 million, down 15.5% from FY2024.

  • Intangibles has now declined for five consecutive years, with a five-year compound annual growth rate of -17.7% (FY2020 to FY2025).
  • In earlier years, Intangibles was $266.65 million in FY2024 (-11.0%), $299.61 million in FY2023 (-12.5%), $342.46 million in FY2022 (-9.1%) and $376.69 million in FY2021 (-36.7%).
  • The Q2 2026 figure marks the lowest quarterly Intangibles since Q1 2020.
  • Compared with a year earlier, Intangibles has declined for 19 straight quarters, with an average decline of 13.7% over the last eight quarters.
  • The best year-over-year quarter for Intangibles over five years was Q3 2021 (growth of 150.4%); the worst was Q3 2023 (a decline of 39.1%).
  • Per Business Quant data, LGND's Intangibles in the three quarters before Q2 2026 was $217.34 million (Q1 2026), $225.44 million (Q4 2025) and $233.54 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Intangibles (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn 48.23 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn 49.14 Bn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn 24.98 Bn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn 42.07 Bn
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn 37.72 Bn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn 20.49 Bn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn 14.03 Bn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn 47.05 Bn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn 412.80 Mn
10 Ligand Pharmaceuticals 6.22 Bn 2.69 Bn - 209.24 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 209.24 Mn
Mar 31, 2026 217.34 Mn
Dec 31, 2025 225.44 Mn
Sep 30, 2025 233.54 Mn
Jun 30, 2025 250.13 Mn
Mar 31, 2025 258.39 Mn
Dec 31, 2024 266.65 Mn
Sep 30, 2024 274.91 Mn
Jun 30, 2024 283.16 Mn
Mar 31, 2024 291.42 Mn
Dec 31, 2023 299.61 Mn
Sep 30, 2023 314.84 Mn
Jun 30, 2023 325.38 Mn
Mar 31, 2023 333.92 Mn
Dec 31, 2022 342.46 Mn
Sep 30, 2022 517.03 Mn
Jun 30, 2022 528.36 Mn
Mar 31, 2022 539.71 Mn
Dec 31, 2021 376.69 Mn
Sep 30, 2021 562.37 Mn
API Access

Ligand Pharmaceuticals Intangibles API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=intangibles&ticker=LGND&period=max&api_key=YOUR_API_KEY